Strong correlations between IGHV, IGHD, and IGHJ genes in CLL malignant clones and other different risk-stratified or prognostic biomarkers were well established in several large series of CLL patients (6–8). This evidence concerns the gene IGHD and B-cell chronic lymphocytic leukemia.